您当前所在位置:首页 > 定制产品 > 新品上市
序号 标题 次数 作者 发布时间
62506 CAS: 2285373-84-2 Ethyl (S)-1-((1-((4-((((4-nitrophenoxy)carbonyl) oxy)methyl)phenyl)amino)-1-oxo-5-ureidopenta n-2-yl)carbamoyl)cyclobutane-1-carboxylate 129 WYQ 2024-12-19
62507 Azido-Phenyl-Amido-SS-Sulfo-NHS Ester, ADC试剂 82 kx 2024-12-19
62508 DOTA-βala-K-NOTA-BBN(7-14)NH2 93 h 2024-12-19
62509 DBCO-PEG3-acetic-Val-Cit-PAB,主要用于合成抗体偶联药物(ADC) 79 WYQ 2024-12-19
62510 Mal-PEG4-Val-Ala-PAB-PNP,ADC定制 62 wyh 2024-12-19
62511 cas:330970-70-2 Alloc-Val-Ala-OH 77 zyl 2024-12-19
62512 DOTA-somatostatin receptor analogs DOTA生长抑素受体类似物 62 h 2024-12-19
62513 CAS: 2754384-60-4,DBCO-(PEG)3-VC-PAB-MMAE 62 WYQ 2024-12-19
62514 Fmoc-Gln(Trt)-PAB-OH, ADC试剂 97 kx 2024-12-19
62515 CAS: 2994332-18-0 ,DBCO-C4-Val-Cit-PABC-PNP,二苯并环辛炔-C4-缬氨酸-瓜氨酸-PABC-对硝基苯基磷酸酯 74 WYQ 2024-12-19
62516 cas:159857-60-0,Fmoc-Lys(MMt)-OH,N-[(9H-芴-9-基甲氧基)羰基]-N'-[(4-甲氧基苯基)二苯基甲基]-L-赖氨酸 153 kx 2024-12-19
62517 DBCO-PEG3-Val-Cit-PAB-PNP,二苯并环辛炔-三聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP 105 WYQ 2024-12-19
62518 NOTA-anti-HER2 NOTA标记抗人表皮生长因子受体2型(HER2)纳米体 102 h 2024-12-19
62519 cas:186023-44-9 Fmoc-Ala-Pro-OH 93 zyl 2024-12-19
62520 TCO-PEG4-Val-Cit-PAB-PNP,反式环辛烯-四聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP 71 WYQ 2024-12-19
62521 Boc-Val-Cit CAS:870487-08-4 89 zyl 2024-12-19
62522 DOTA-Bn-FGK-Fab DOTA标记抗体片段 99 h 2024-12-19
62523 cas:252554-78-2,Fmoc-Ala-Ser (Psi(Me,Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 56 kx 2024-12-19
62524 DOTA-Nal3-Octreotide DOTANOC DOTA-Nal3-奥曲肽 91 h 2024-12-19
62525 cas:2413428-36-9,MC-Gly-Gly-Phe-Gly,(S)-5-苄基-18-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-4,7,10,13-四氧代-3,6,9,12-四氮杂十八烷-1-酸 73 kx 2024-12-19
62526 MC-Val-Cit-PAB-PNP CAS:159857-81-5 109 zyl 2024-12-19
62527 cas:2353409-52-4,Mal-amido-PEG8-Val-Gly-PAB-OH,马来酰亚胺-酰胺-八聚乙二醇-VAL-GLY-PAB-羟基 65 kx 2024-12-19
62528 Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB CAS:2055042-69-6 65 zyl 2024-12-19
62529 cas:1895916-22-9,MC-Val-Ala-OH, ADC试剂 66 kx 2024-12-19
62530 cas:159857-70-2,MC-Val-Cit-Doxorubicin,MC-VAL-CIT-阿霉素 58 kx 2024-12-19
62531 DOTA−Gal-NAPamide DOTA−Gal-纳帕胺 64 h 2024-12-19
62532 DOTA-peptide-Lym-1 radioimmunotherapy DOTA-肽-Lym-1 76 h 2024-12-19
62533 N-DBCO-N-bis(PEG2-amide-PEG4-Val-cit-PAB-MMAE), N-二苯并环辛炔-N-双(二聚乙二醇-酰胺-四聚乙二醇-VAL-CIT-PAB-MMAE) 84 kx 2024-12-19
62534 DOTA-dGlu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 85 h 2024-12-19
62535 DOTA-MGO DOTA-DGlu-(Glu)s-minigastrin 69 h 2024-12-19
62536 cas:2762518-86-3,NHS Ester-PEG4-Val-Cit-PAB-MMAE, ADC试剂 119 kx 2024-12-19
62537 DOTA-scFv-anti-PSMA DOTA-scFv-抗PSMA脂质纳米粒(LNPs) 69 h 2024-12-19
62538 cas:2353409-45-5,BCN-PEG3-Val-Cit-PFP Ester, ADC试剂 64 kx 2024-12-19
62539 cas:2112738-13-1,Mal-amido-PEG2-Val-Cit-PAB-PNP, ADC试剂 69 kx 2024-12-19
62540 cas:2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH, ADC试剂 66 kx 2024-12-19
62541 cas:2055024-62-7,NH2-PEG3-Val-Cit-PAB-OH, ADC试剂 117 kx 2024-12-19
62542 Fmoc-PEG3-Val-Cit,N-芴甲氧羰基-三聚乙二醇-VAL-CIT 84 kx 2024-12-19
62543 DOTA-anti-VLA-4 70 h 2024-12-19
62544 DOTA-glycylglycylglycyl-l-p-isothiocyanatophenylalanine amide 73 h 2024-12-19
62545 CAS: 2748039-76-9, Alkyne-Val-Cit-PAB-FAM,炔-Val-Cit-PAB-FAM 65 WYQ 2024-12-19
62546 CAS:646502-53-6 MC-Val-Cit-PAB-MMAE的结构式 93 zyl 2024-12-19
62547 Amino-PEG2-VG-N-Bis(PEG1-azide),氨基-二聚乙二醇-VG-N-双(一聚乙二醇-叠氮) 81 WYQ 2024-12-19
62548 Azido-PEG8-Val-Cit-PAB-PNP,C34H47N9O12 81 WYQ 2024-12-19
62549 化合物:TCO-MMAE,反式环辛烯-MMAE(其中MMAE为单甲基澳瑞他汀E的缩写) 110 WYQ 2024-12-19
62550 cas:2748039-77-0,Alkyne-Val-Cit-PAB-PNP,炔-VAL-CIT-PAB-PNP 酯 78 kx 2024-12-19
库存查询